YOLFTbeta
Marker Therapeutics Inc

Marker Therapeutics Inc

MRKR · NASDAQ · Healthcare / Biotechnology

0.87USD-0.03 (-3.33%)

Price History

Full chart

Market Stats

Previous Close0.90
Open0.92
Day Range0.87 – 0.93
52-Week Range0.84 – 2.46
Volume76.10K
Market Cap18.76M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.38
Dividend Yield0.00%
Beta1.53
50-Day Avg1.22
200-Day Avg1.43

About

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, develops and commercializes T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications in the United States. The company's multi antigen recognizing (MAR)-T cell therapy technology is based on the selective expansion of non-engineered tumor-specific T cells that recognize tumor-associated antigens and kill tumor cells expressing those targets. It develops MT-601, which is in Phase 1 trials for the treatment of lymphoma and pancreatic cancer; and MT-401-OTS, which is in a Phase 1 trial for the treatment of acute myeloid leukemia and myelodysplastic syndromes. The company was formerly known as TapImmune, Inc. and changed its name to Marker Therapeutics, Inc. in October 2018. Marker Therapeutics, Inc. was founded in 1999 and is headquartered in Houston, Texas.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEODr. Juan F. Vera M.D.
  • Employees5
  • Headquarters2450 Holcombe Blvd, Houston, TX, United States, 77021, USA
  • Websitehttps://markertherapeutics.com

Leadership

  • Dr. Juan F. Vera M.D.Co-Founder, CEO, President, Treasurer, Secretary & Director · b. 1980
  • Ms. Elizabeth DonnellyDirector of Administration
  • Dr. Maria-Bernadette Madel Ph.D.Director of Corporate Operations & External Communications · b. 1990
  • Mr. Edmund CheungVice President of Human Resources
  • Patricia AllisonHead of Clinical Operations
  • Ms. Mary Newman Ph.D.Head of Regulatory Affairs · b. 1959
  • Dr. Robert Z. Florkiewicz Sr., Ph.D.Senior Director of Molecular Biology & Virology

Financials

Income Statement

Currency: USD1999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue120.72K31.81K-------------000183.06K205.99K213.19K466.79K1.24M3.51M3.31M6.59M3.55M
Growth (%)--73.65%-----------------+12.53%+3.50%+118.95%+166.01%+182.96%-5.76%+99.06%-46.19%
Cost of Revenue38.60K2.47K---37.45K30.71K6.37K5.97K7.48K3.74K----264.00K0005.25M124.00M12.76M18.88M3.16M11.97M10.42M13.47M-
Gross Profit82.12K22.42K------------264.00K000-5.07M-123.79M-12.55M-18.41M-1.92M-8.45M-7.11M-6.88M-
Gross Margin68.03%70.48%-----------------2768.43%-60094.95%-5887.41%-3944.86%-154.70%-240.64%-214.60%-104.33%-
Operating Expense1.15M1.49M------------2.93M3.37M6.16M8.49M6.41M24.38M9.98M10.47M37.56M11.34M7.48M4.24M-
Operating Income-1.06M-1.47M-379.86K-2.29M-5.78M-2.68M-1.01M-888.00K-2.51M-1.50M-4.19M-3.94M-2.64M-6.22M-2.66M-3.37M-6.16M-8.49M-11.48M-148.17M-22.53M-28.89M-39.48M-19.79M-14.58M-11.12M-12.89M
Operating Margin-882.24%-4612.85%-----------------6271.03%-71930.25%-10567.28%-6188.29%-3179.32%-563.28%-440.37%-168.69%-363.45%
EBITDA-1.05M-457.20K-384.54K-2.24M-5.74M-2.65M-838.00K-851.00K-2.50M-1.41M-3.27M-3.85M-1.35M-5.58M-3.78M-30.31M-34.06M6.04M-11.30M-147.97M-22.42M-27.63M-38.72M-16.99M-11.25M-10.68M-12.44M
EBITDA Margin-867.33%-1437.24%-----------------6171.07%-71830.25%-10517.97%-5919.21%-3117.98%-483.47%-339.86%-162.06%-350.68%
Net Income-1.13M-1.29M-384.54K-2.29M-5.78M-2.68M-990.00K-1.30M-3.89M-2.20M-4.46M-5.09M-2.03M-5.86M-5.53M-30.88M-34.07M-2.46M-10.98M-147.96M-21.43M-28.71M-41.88M-29.93M-8.24M-10.73M-12.16M
Net Income Margin-933.60%-4060.96%-----------------5998.99%-71826.36%-10050.92%-6149.73%-3372.68%-851.87%-248.76%-162.82%-342.96%
R&D294.92K5.00K-833.59K1.73M1.04M248.36K173.17K425.57K182.34K93.04K290.05K203.72K1.06M661.63K189.00K1.71M3.80M5.25M124.00M12.76M18.88M27.79M11.97M10.42M13.47M11.80M
R&D as % of Total Revenue244.31%15.72%----------------2868.40%60194.96%5987.41%4044.90%2238.44%340.64%314.60%204.33%332.68%
Interest Expense1.13M1.29M379.86K2.29M5.78M2.68M116.82K446.60K1.38M778.18K1.19M1.24M679.33K745.07K1.76M575.54K10.93K0000148.74K5.70K15.09K---
Interest Expense % of Total Revenue933.87%4060.96%----------------0.00%0.00%0.00%31.87%0.46%0.43%---

Balance Sheet

Currency: USD1999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets148.28K120.79K-761.43K93.21K88.19K89.86K154.34K279.11K52.91K356.96K116.43K340.21K104.21K77.03K224.45K6.65M7.92M5.18M62.14M46.36M45.61M68.14M34.42M17.13M22.02M19.07M
Total Liabilities289.71K682.74K173.03K295.60K736.95K2.53M2.31M3.15M1.95M3.08M986.35K3.39M3.80M5.77M8.85M1.25M28.01M1.74M1.52M2.80M2.27M18.27M24.15M14.82M3.07M3.46M2.27M
Total Equity-141.42K-561.95K-173.03K465.83K-643.75K-2.44M-2.22M-3.00M-1.67M-3.02M-629.39K-3.27M-3.46M-5.67M-8.77M-1.02M-21.36M6.18M3.66M59.34M44.09M27.34M43.99M19.60M14.05M18.56M16.80M
Cash43.58K190.00K10.00K642.59K19.45K11.65K56.24K120.44K167.54K987141.43K23.52K250.23K50.68K48.59K141.94K6.58M7.85M5.13M61.75M43.90M21.35M42.35M11.78M15.11M19.19M16.07M
Total Debt153.30K194.79K70.00K--477.10K542.67K583.34K650.85K819.96K338.02K919.81K1.11M1.45M3.48M52.94K53.00K5.00K5.00K-484.38K12.26M11.87M7.62M---
Net Debt109.72K4.79K60.00K-642.59K-19.45K465.45K486.42K462.91K483.31K818.97K196.59K896.29K855.56K1.40M3.43M-89.00K-6.52M-7.85M-5.12M-61.75M-43.42M-9.10M-30.48M-4.17M-15.11M-19.19M-16.07M

Cash Flow

Currency: USD1999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-815.18K-879.74K2.38K-1.41M-2.59M-1.21M-1.16M-1.19M-1.23M-714.42K-1.12M-925.04K-1.31M-1.57M-694.58K-2.19M-4.34M-6.51M-8.44M-14.48M-18.28M-20.03M-27.28M-26.97M-16.44M-10.91M-12.01M
Investing Cash Flow-36.76K-2.86K-417.55K-2.25K-2.25K-1.97K-1.97K-22.43K--------147.67K-147.67K-147.67K-147.67K-374.98K-9.25M-3.13M-4.95M18.66M--
Financing Cash Flow888.21K807.79K-2.38K1.63M2.01M1.22M1.21M1.22M1.32M547.87K1.26M807.13K1.54M1.37M709.33K2.28M10.78M7.78M5.72M71.25M816.48K6.74M52.56M202.13K1.11M14.99M9.86M
Capital Expenditure54.03K2.86K05.82K2.25K01.97K022.43K22.43K000000147.67K147.67K147.67K147.67K374.99K9.25M3.13M3141
Free Cash Flow-869.21K-882.60K2.38K-1.41M-2.59M-1.21M-1.17M-1.19M-1.25M-714.42K-1.12M-925.04K-1.31M-1.57M-694.58K-2.19M-4.34M-6.51M-8.44M-14.63M-18.66M-29.29M-30.41M-26.97M-16.44M-10.91M-12.01M
FCF to OCF106.63%100.33%100.00%100.41%100.09%100.00%100.17%100.00%101.83%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%101.02%102.05%146.18%111.48%100.00%100.00%100.00%100.00%

Earnings

Report DateSep 30, 1999Mar 31, 2000Jun 30, 2000Sep 30, 2000Mar 31, 2001Jun 30, 2001Sep 30, 2001Mar 31, 2002Jun 30, 2002Sep 30, 2002Mar 31, 2003Jun 30, 2003Sep 30, 2003Dec 31, 2003Mar 31, 2004Jun 30, 2004Sep 30, 2004Dec 31, 2004Mar 31, 2005Jun 30, 2005Sep 30, 2005Dec 31, 2005Mar 31, 2006Jun 30, 2006Sep 30, 2006Dec 31, 2006Mar 31, 2007Jun 30, 2007Sep 30, 2007Dec 31, 2007Mar 31, 2008Jun 30, 2008Sep 30, 2008Dec 31, 2008Mar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013May 28, 2014Aug 18, 2014Nov 19, 2014Feb 25, 2015Apr 15, 2015Aug 14, 2015Nov 16, 2015Mar 2, 2016May 16, 2016Aug 15, 2016Nov 4, 2016Mar 14, 2017May 5, 2017Aug 7, 2017Nov 14, 2017Mar 23, 2018May 15, 2018Aug 9, 2018Nov 13, 2018Mar 15, 2019May 10, 2019Aug 8, 2019Nov 12, 2019Mar 12, 2020May 11, 2020Aug 10, 2020Nov 9, 2020Mar 9, 2021May 12, 2021Aug 10, 2021Nov 9, 2021Mar 17, 2022May 13, 2022Aug 11, 2022Nov 10, 2022Mar 22, 2023May 15, 2023Aug 14, 2023Nov 9, 2023Mar 26, 2024May 15, 2024Aug 14, 2024Nov 14, 2024Mar 24, 2025May 15, 2025Aug 14, 2025Nov 13, 2025Mar 19, 2026May 15, 2026Aug 14, 2026Nov 12, 2026
EPS Estimate--------------------------------------------------------14.40-13.20--13.20-----------5.00-0.30--4.40-2.03-1.30-1.27-1.32-1.26-1.23-1.43-1.45-1.60-1.45-1.17-1.27-1.27-1.33-1.03-1.30-1.00-0.80---1.00-0.25-0.43-0.39-0.22-0.66-0.27-0.21-0.19-0.19-0.25-0.12
EPS Actual-346629.74-316216.94-338027.74-329043.10-320078.9038420.19-22692.10-64291.26-126055.07-11131.42-16151.35-22846.28-17231.64-46296.43-10340.12-7781.37-5960.19-15000.00-295.23-4727.32-3204.78-2012.22-3761.59-2403.78-4323.78-6000.00-10758.96-4744.60-2823.98-6000.00-3455.63-3828.81-1329.91-2467.16-2248.06571.31-263.75-1800.00-504.70-390.85-344.08-304.86-334.03-103.96-214.5891.08-136.89-532.55-126.04-318.51-160.05-104.40-91.59-344.40-514.416.00-10.80-4.3532.40-6.600.37-29.12-0.810.35-0.29-0.19-0.29-0.22-0.39-3.00-0.30-0.41-3.20-10.20-1.20-1.20-1.20-1.10-1.40-1.40-1.60-1.80-1.60-1.30-1.50-1.10-1.20-1.10-0.80-3.27-0.570.29-0.34-0.48-0.27-0.25-0.26-0.42-0.40-0.29-0.12-0.04-0.16-0.09-
Surprise-------------------------------------------------------141.67%18.18%-345.45%----------40.00%0.00%-27.27%-402.46%7.69%5.51%9.09%12.70%-13.82%2.10%-10.34%-12.50%-10.34%-11.11%-18.11%13.39%9.77%-6.80%38.46%-227.00%28.80%--52.00%-8.00%41.86%33.33%-90.91%39.39%-7.41%42.86%78.95%15.79%64.00%-
Timing-------------------------------------------------------After-hoursAfter-hours-After-hoursAfter-hoursPre-market-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hours-

Key Statistics & Ratios

Market Cap18.76M
Enterprise Value9.34M
Trailing P/E0.00
Forward P/E0.00
Price / Sales5.29
Price / Book1.70
EPS-0.38
Book Value0.73
Revenue (TTM)3.55M
Gross Profit (TTM)-5.26M
EBITDA-11.79M
Profit Margin-245.51%
Operating Margin-267.95%
Return on Equity-76.87%
Return on Assets-40.47%
Shares Outstanding16.67M
Shares Float13.74M
Beta1.53
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 2 analystsTarget 7.87
  • Strong Buy
    2

Ownership Breakdown

Institutions
23.80%
Insiders
5.49%
Retail / Other
70.71%

Top Institutional Holders

  • NEA Management Company, LLC
    1.63M9.75%
  • Blue Owl Capital Holdings LP
    554.25K3.32%
  • Vanguard Capital Management, LLC
    389.32K2.33%
  • Aisling Capital Management LP
    325.37K1.95%
  • Renaissance Technologies Corp
    175.29K1.05%
  • Geode Capital Management, LLC
    160.91K0.97%
  • Advisor Group Holdings, Inc.
    93.12K0.56%
  • Vanguard Fiduciary Trust Co
    87.27K0.52%
  • LPL Financial Corp
    83.05K0.50%
  • XTX Topco Ltd
    63.57K0.38%
  • Two Sigma Investments LLC
    60.20K0.36%
  • Susquehanna International Group, LLP
    48.78K0.29%
  • Jane Street Group LLC
    36.30K0.22%
  • Citadel Advisors Llc
    32.52K0.20%
  • UBS Group AG
    32.37K0.19%
  • Invst LLC
    29.00K0.17%
  • Northern Trust Corp
    26.01K0.16%
  • State Street Corp
    20.95K0.13%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    298.09K1.79%
  • Fidelity Extended Market Index
    72.01K0.43%